Year-end report January 1 – December 31, 2022

Strengthened result under continued cost pressureOctober 1 - December 31 · Net sales amounted to SEK 1,974 m (1,552), corresponding to a 27.2% increase in sales. At fixed exchange rates, this corresponds to a 19.0% increase. · Operating income amounted to SEK 153 m (110). · Strong growth compared to the previous year, although continued cost increases are putting pressure on the operating margin. · Strengthened balance sheet following divestment of 25% of the shares in the Australian company BioPak Pty Ltd. January 1 – December 31 · Net sales amounted to SEK 6,976 m (5,